Whereas vaccine research are carried out on completely different age ranges inside the scope of combating coronavirus round the world, the European Medicines Company (EMA) accepted the use of the vaccine developed towards coronavirus by the US pharmaceutical large Pfizer and its German companion BioNTech in youngsters aged 12-15.
“TO BE APPLIED IN TWO INJECTIONS AT AT LEAST 3 WEEKS”
Marco Cavaleri, Head of Organic Well being Threats and Vaccines Technique at EMA, introduced at a press convention that EMA’s Human Medicines Committee has accepted the use of the Pfizer/BioNTech vaccine in youngsters aged 12-15 years.
Cavaleri said that the really helpful use of the vaccine in youngsters aged 12-15 would be the similar as in individuals aged 16 and over. “The vaccine will be administered as two injections into the arm muscle tissues a minimum of 3 weeks aside” mentioned.
IT WAS THE FIRST VACCINE TO BE APPLIED ON CHILDREN
The Pfizer/BioNTech vaccine was the first vaccine accepted by the EMA to be used in youngsters aged 12-15 in 27 European Union (EU) member nations.
Because of the scientific research during which the BioNTech/Pfizer vaccine was examined in youngsters in the USA and Canada, it was decided that the vaccine protects youngsters between the ages of 12-15 towards coronavirus illness.
MILD SIDE EFFECTS OBSERVED
In accordance to the outcomes of the research, gentle uncomfortable side effects similar to fatigue and headache have been noticed in youngsters after vaccination. It was famous that the optimistic consequence obtained from the research gave the inexperienced mild to testing in youthful age teams and pregnant ladies.
PROVIDED 100 PERCENT PROTECTION
Specialists evaluated the information they collected from 2,260 youngsters between the ages of 12-15 in the research. Two doses of vaccine have been administered to 1131 youngsters with an interval of 21 days, and placebo was administered to 1,129 youngsters. In the research, the place the vaccine was discovered to defend youngsters who acquired two doses of vaccine one hundred pc in contrast to the placebo group, it was emphasised that no extreme uncomfortable side effects similar to thrombosis have been encountered after two doses.
German BioNTech firm and its US companion Pfizer applied to the European Medicines Company (EMA) at the finish of April in order that the coronavirus vaccine they developed can be utilized in the 12-15 age group.
CAN BE APPLIED TO 12-15 AGE GROUP
The European Medicines Company reported that BioNTech-Pfizer’s coronavirus vaccine can be administered to the 12-15 age group.
#BioNTechPfizers #coronavirus #vaccine #applied #age #group
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.